← Leaderboards
Geoffrey A. Walford
Massachusetts General Hospital
$338,237
Attributed
$338,237
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $146.7K · FY2014–16$200K$150K$100K$50K$0
'14
'15
'16
Funding mix
By agency
NIH$338,237 · 1
By mechanism
K23$338,237 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jose Carlos Florez$39,251,920
- James B Meigs$19,655,119
- Sekar Kathiresan$50,580,753
- Steven Kyle Grinspoon$75,757,679
- Mary F McNaughton-Collins$1,571,675
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAmputationArtsAwardBiochemicalBiologicalBlindnessBranched-Chain Amino AcidsCareerCareer DevelopmentCharacteristicsChronicChronic Kidney FailureClinical MedicineClinical SciencesClinical TrialsDevelopment PlansDiabetes MellitusDiabetes Mellitus TherapyDiabetes PreventionDiabetes Prevention ProgramElementsEndocrinologyAcute
Grant awards (3)
Development of a Metabolite Signature of Metformin Prevention for Type 2 Diabetes$47,599
K23 · FY2016 · DK · contact PI
Development of a Metabolite Signature of Metformin Prevention for Type 2 Diabetes$146,696
K23 · FY2015 · DK · contact PI
Development of a Metabolite Signature of Metformin Prevention for Type 2 Diabetes$143,942
K23 · FY2014 · DK · contact PI